Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 397 results for "ranbaxy laboratories"

Sun Pharmaceutical gets US nod to buy Ranbaxy
Manorama Online

Sun Pharmaceutical gets US nod to buy Ranbaxy

Washington: India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday. Sun ... Manorama Online, 9 hours ago
Sun Pharma Wins US Nod to Buy Ranbaxy NDTV Profit, 13 hours ago
[x]  

9 images for ranbaxy laboratories

India Infoline, 16 hours ago
Financial Express, 3 days ago
Reuters, 3 days ago
Financial Express, 7 hours ago
Money Today, 3 days ago
Sify, 3 days ago
Sify, 10 hours ago
First Post.com, 1 day ago
Calcutta Telegraph, 2 days ago
Business Standard India

US regulator imposes conditions on Sun's Ranbaxy acquisition

Pharmaceutical Industries and Ranbaxy Laboratories have agreed to divest the latter's interests in generic minocycline tablets in order to settle charges that Sun's proposed acquisition of Ranbaxy would likely be anti-competitive.An American federal ...
 24Dunia3 hours ago US FTC gives conditional nod to Sun-Ranbaxy merger  Smart Investor11 hours ago FTC imposes conditions on Sun-Ranbaxy deal  Business Standard India11 hours ago Sun Pharma-Ranbaxy deal: US regulator imposes conditions  ZeeNews.com13 hours ago
[x]  
Financial Express

Sun-Ranbaxy deal: US FTC asks Ranbaxy to divest asset

To address monopoly concerns, the FTC said Sun Pharmaceutical Industries and Ranbaxy Laboratories have agreed to divest the latter's interests in generic minocycline tablets.Reuters After Competition Commission of India, US fair trade watchdog ...
 Financial Express7 hours ago Sun-Ranbaxy deal: Ranbaxy asked to divest asset  Business Today India7 hours ago Ranbaxy asked to divest asset  The Statesman25 minutes ago
[x]  
The Telegraph

Pharmaceutical Newsletter - January 27 to 30, 2015

Ranbaxy Laboratories Ltd has posted a net profit/(loss) after tax, minority interest and share in loss of associates of Rs. (10297.27) mn for the quarter ended December 31, 2014 as compared to net loss of Rs. (1589.44) mn for the quarter ended December 31, ...
 India Infoline1 day ago United States : USFDA calls off approval for Ranbaxy s capsules [TendersInfo (India)]  Pharmacy Choice1 day ago Ranbaxy loss widens  24Dunia2 days ago Ranbaxy Q3 loss widens to ₹1,030 cr  Hindu Business Line3 days ago
[x]  

Ranbaxy Laboratories 3Q Net Loss INR 10.3 Bln

By Sean McLain NEW DELHIRanbaxy Laboratories Ltd. returned to a loss last quarter as sales flagged and a one-off tax payment weighed on earnings. The generic-drug maker reported an after-tax loss of 10.3 billion rupees ($167.7 million) in the ...
 iMarketReports3 days ago TCS eyes $5 billion from digital vertical; hires over 1500 this fiscal  24Dunia3 days ago Ranbaxy Laboratories Returns to a Loss in Oct-Dec  4 Traders3 days ago

Ranbaxy Labs Q3 revenue may rise 12% to Rs 3236 cr: Poll

Ranbaxy Laboratories, which will soon become a part of Sun Pharma, will announce its third quarter (October-December) earnings today. Analysts expect the quarter to be a good one due to Diovan generic (is used to treat high blood pressure).
 Money Control3 days ago

USFDA revokes approval for Ranbaxy's capsules

Comment · print · T T T+· T- TOPICS In more trouble for Ranbaxy Laboratories, the U.S. Food and Drug Administration (FDA) has revoked the Indian company's 180-day exclusivity to market esomeprazole magnesium delayed release capsule 20 ...
 The Hindu4 days ago
Financial Express

India's Sun Pharma looks ahead on verge of Ranbaxy deal approval

SINGAPORE--After seemingly taking forever, Sun Pharmaceuticals' $4 billion takeover of the embattled Ranbaxy Laboratories could win final approval as soon as Feb. 2--and close by mid-month. Seller Daiichi Sankyo will be glad to see it go. Sun ...
 FiercePharma5 days ago Columns: CCI's Sun-Ranbaxy master stroke  Financial Express1 month ago INCHING TOWARDS A GRAND MERGER  PharmaBiz1 month ago Divestment of 7 products may not impact working of Sun-Ranbaxy merger  PharmaBiz1 month ago
[x]  
International Business Times India

FTC Puts Conditions on Sun Pharmaceutical's Proposed Acquisition of Ranbaxy

Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy's interests in generic minocycline tablets in order to settle Federal Trade Commission charges that Sun's $4 billion proposed ...
 Noodls1 day ago Federal Trade Commission : FTC Puts Conditions on Sun Pharmaceutical's Proposed Acquisition of Ranbaxy  4 Traders1 day ago Ranbaxy Posts Loss after Write-offs on US Import Bans  International Business Times India1 month ago

Ranbaxy Laboratories allots equity shares

Ranbaxy Laboratories announced that the ESOPs Allotment Committee of Directors at its meeting held on 22 January 2015, allotted 6,40,597 Equity Shares on exercise of stock options under the Employees Stock Option Scheme(s) of the Company. The ...
 HDFC Securities1 week ago Ranbaxy Laboratories allots equtiy shares  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less